CRISPR, mRNA Platforms, and Cell Therapy Technologies Redefine Red Biotechnology Market Potential
The global red biotechnology market reached a valuation of USD 531.66 billion in 2024, with a projected CAGR of 10.31% from 2025 to 2034, driven by distinct segment-level growth patterns across product types, end-users, and therapeutic applications. Biopharmaceuticals—particularly monoclonal antibodies, recombinant proteins, and gene therapies—represent the largest revenue segment,...